However, recent studies using knock‐in mice demonstrate that non‐activating αIIbβ3 mutations can also cause macrothrombocytopenia by disrupting the RhoA/cytoskeletal axis, providing the first evidence that constitutive αIIbβ3 activation is not an essential prerequisite for this disorder. Here, RHOA is linked to Macrothrombocytopenia.